UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 203

Sortiert nach

A synthetic lipopeptide targeting top-priority multidrug-resistant Gram-negative pathogens

Nature communications, 2022-03, Vol.13 (1), p.1625-15, Article 1625

2022

Volltextzugriff (PDF)

Complete genome sequence and genome-scale metabolic modelling of Acinetobacter baumannii type strain ATCC 19606

International journal of medical microbiology, 2020-04, Vol.310 (3), p.151412-151412, Article 151412

2020

Volltextzugriff (PDF)

Multifaceted mechanisms of colistin resistance revealed by genomic analysis of multidrug-resistant Klebsiella pneumoniae isolates from individual patients before and after colistin treatment

The Journal of infection, 2019-10, Vol.79 (4), p.312-321

2019

Volltextzugriff (PDF)

Arginine catabolism is essential to polymyxin dependence in Acinetobacter baumannii

Cell reports (Cambridge), 2024-07, Vol.43 (7), p.114410, Article 114410

2024

Volltextzugriff (PDF)

The Combination of Colistin and Doripenem Is Synergistic against Klebsiella pneumoniae at Multiple Inocula and Suppresses Colistin Resistance in an In Vitro Pharmacokinetic/Pharmacodynamic Model

Antimicrobial Agents and Chemotherapy, 2012-10, Vol.56 (10), p.5103-5112

2012

Volltextzugriff (PDF)

Comparative Metabolomics Reveals Key Pathways Associated With the Synergistic Killing of Colistin and Sulbactam Combination Against Multidrug-Resistant Acinetobacter baumannii

Frontiers in pharmacology, 2019-07, Vol.10, p.754-754

2019

Volltextzugriff (PDF)

Polymyxins Bind to the Cell Surface of Unculturable Acinetobacter baumannii and Cause Unique Dependent Resistance

Advanced science, 2020-08, Vol.7 (15), p.2000704-n/a

2020

Volltextzugriff (PDF)

Metabolic Analyses Revealed Time-Dependent Synergistic Killing by Colistin and Aztreonam Combination Against Multidrug-Resistant Acinetobacter baumannii

Frontiers in microbiology, 2018-11, Vol.9, p.2776-2776

2018

Volltextzugriff (PDF)

Lipid A Modification and Metabolic Adaptation in Polymyxin-Resistant, New Delhi Metallo-β-Lactamase-Producing Klebsiella pneumoniae

Microbiology spectrum, 2023-08, Vol.11 (4), p.e0085223-e0085223

2023

Volltextzugriff (PDF)

Comparative metabolomics revealed key pathways associated with the synergistic killing of multidrug-resistant Klebsiella pneumoniae by a bacteriophage-polymyxin combination

Computational and structural biotechnology journal, 2022-01, Vol.20, p.485-495

2022

Volltextzugriff (PDF)

An Efficient Approach for the Design and Synthesis of Antimicrobial Peptide-Peptide Nucleic Acid Conjugates

Frontiers in chemistry, 2022-03, Vol.10, p.843163-843163

2022

Volltextzugriff (PDF)

Anthelmintic closantel enhances bacterial killing of polymyxin B against multidrug-resistant Acinetobacter baumannii

Journal of antibiotics, 2016-06, Vol.69 (6), p.415-421

2016

Volltextzugriff (PDF)

Clinically Relevant Concentrations of Polymyxin B and Meropenem Synergistically Kill Multidrug-Resistant Pseudomonas aeruginosa and Minimize Biofilm Formation

Antibiotics (Basel), 2021-04, Vol.10 (4), p.405

2021

Volltextzugriff (PDF)

Therapeutic Potential of Intravenous Phage as Standalone Therapy for Recurrent Drug-Resistant Urinary Tract Infections

Antimicrobial agents and chemotherapy, 2023-04, Vol.67 (4), p.e0003723-e0003723

2023

Volltextzugriff (PDF)

Spray-freeze-dried inhalable composite microparticles containing nanoparticles of combinational drugs for potential treatment of lung infections caused by Pseudomonas aeruginosa

International journal of pharmaceutics, 2021-12, Vol.610, p.121160-121160, Article 121160

2021

Volltextzugriff (PDF)

Co-Delivery of Ciprofloxacin and Colistin in Liposomal Formulations with Enhanced In Vitro Antimicrobial Activities against Multidrug Resistant Pseudomonas aeruginosa

Pharmaceutical research, 2018-10, Vol.35 (10), p.187-13, Article 187

2018

Volltextzugriff (PDF)

Critical Role of Position 10 Residue in the Polymyxin Antimicrobial Activity

Journal of medicinal chemistry, 2023-02, Vol.66 (4), p.2865-2876

2023

Volltextzugriff (PDF)

Model-informed dose optimisation of polymyxin-rifampicin combination therapy against multidrug-resistant Acinetobacter baumannii

International journal of antimicrobial agents, 2023-09, Vol.62 (3), p.106902-106902, Article 106902

2023

Volltextzugriff (PDF)

Composite particle formulations of colistin and meropenem with improved in-vitro bacterial killing and aerosolization for inhalation

International journal of pharmaceutics, 2018-09, Vol.548 (1), p.443-453

2018

Volltextzugriff (PDF)

Synergistic Antibiotic Combination Powders of Colistin and Rifampicin Provide High Aerosolization Efficiency and Moisture Protection

The AAPS journal, 2014-01, Vol.16 (1), p.37-47

2014

Volltextzugriff (PDF)

Effects of the antibiotic component on in-vitro bacterial killing, physico-chemical properties, aerosolization and dissolution of a ternary-combinational inhalation powder formulation of antibiotics for pan-drug resistant Gram-negative lung infections

International journal of pharmaceutics, 2019-04, Vol.561, p.102-113

2019

Volltextzugriff (PDF)

Polymyxin resistance in Klebsiella pneumoniae: multifaceted mechanisms utilized in the presence and absence of the plasmid-encoded phosphoethanolamine transferase gene mcr-1

Journal of antimicrobial chemotherapy, 2019-11, Vol.74 (11), p.3190-3198

2019

Volltextzugriff (PDF)

Novel Polymyxin Combination with the Antiretroviral Zidovudine Exerts Synergistic Killing against NDM-Producing Multidrug-Resistant Klebsiella pneumoniae

Antimicrobial agents and chemotherapy, 2019-04, Vol.63 (4)

2019

Volltextzugriff (PDF)

In vitro pharmacokinetics/pharmacodynamics of continuous ceftazidime infusion alone and in combination with colistin against Pseudomonas aeruginosa biofilm

International journal of antimicrobial agents, 2021-02, Vol.57 (2), p.106246, Article 106246

2021

Volltextzugriff (PDF)

Phage resistance in Klebsiella pneumoniae and bidirectional effects impacting antibiotic susceptibility

Clinical microbiology and infection, 2024-06, Vol.30 (6), p.787-794

2024

Volltextzugriff (PDF)

1 – 25 von 203

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(195)
Mit Volltextzugriff
(180)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(174)
Life Sciences & Biomedicine
(133)
Humans
(96)
Male
(48)
Female
(45)
Animals
(34)
Pharmacology & Pharmacy
(28)
Physical Sciences
(25)
Mice
(23)
Biological And Medical Sciences
(22)
Adult
(20)
Biochemistry & Molecular Biology
(20)
Infectious Diseases
(19)
Medical Sciences
(19)
Microbiology
(19)
Science & Technology - Other Topics
(19)
Chemistry
(18)
Technology
(18)
Genetics & Heredity
(16)
Anti-Bacterial Agents - Pharmacology
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

A synthetic lipopeptide targeting top-priority multidrug-resistant Gram-negative pathogens

Complete genome sequence and genome-scale metabolic modelling of Acinetobacter baumannii type strain ATCC 19606

Multifaceted mechanisms of colistin resistance revealed by genomic analysis of multidrug-resistant Klebsiella pneumoniae isolates from individual patients before and after colistin treatment

Arginine catabolism is essential to polymyxin dependence in Acinetobacter baumannii

The Combination of Colistin and Doripenem Is Synergistic against Klebsiella pneumoniae at Multiple Inocula and Suppresses Colistin Resistance in an In Vitro Pharmacokinetic/Pharmacodynamic Model

Comparative Metabolomics Reveals Key Pathways Associated With the Synergistic Killing of Colistin and Sulbactam Combination Against Multidrug-Resistant Acinetobacter baumannii

Polymyxins Bind to the Cell Surface of Unculturable Acinetobacter baumannii and Cause Unique Dependent Resistance

Metabolic Analyses Revealed Time-Dependent Synergistic Killing by Colistin and Aztreonam Combination Against Multidrug-Resistant Acinetobacter baumannii

Lipid A Modification and Metabolic Adaptation in Polymyxin-Resistant, New Delhi Metallo-β-Lactamase-Producing Klebsiella pneumoniae

Comparative metabolomics revealed key pathways associated with the synergistic killing of multidrug-resistant Klebsiella pneumoniae by a bacteriophage-polymyxin combination

An Efficient Approach for the Design and Synthesis of Antimicrobial Peptide-Peptide Nucleic Acid Conjugates

Anthelmintic closantel enhances bacterial killing of polymyxin B against multidrug-resistant Acinetobacter baumannii

Clinically Relevant Concentrations of Polymyxin B and Meropenem Synergistically Kill Multidrug-Resistant Pseudomonas aeruginosa and Minimize Biofilm Formation

Therapeutic Potential of Intravenous Phage as Standalone Therapy for Recurrent Drug-Resistant Urinary Tract Infections

Spray-freeze-dried inhalable composite microparticles containing nanoparticles of combinational drugs for potential treatment of lung infections caused by Pseudomonas aeruginosa

Co-Delivery of Ciprofloxacin and Colistin in Liposomal Formulations with Enhanced In Vitro Antimicrobial Activities against Multidrug Resistant Pseudomonas aeruginosa

Critical Role of Position 10 Residue in the Polymyxin Antimicrobial Activity

Model-informed dose optimisation of polymyxin-rifampicin combination therapy against multidrug-resistant Acinetobacter baumannii

Composite particle formulations of colistin and meropenem with improved in-vitro bacterial killing and aerosolization for inhalation

Synergistic Antibiotic Combination Powders of Colistin and Rifampicin Provide High Aerosolization Efficiency and Moisture Protection

Effects of the antibiotic component on in-vitro bacterial killing, physico-chemical properties, aerosolization and dissolution of a ternary-combinational inhalation powder formulation of antibiotics for pan-drug resistant Gram-negative lung infections

Polymyxin resistance in Klebsiella pneumoniae: multifaceted mechanisms utilized in the presence and absence of the plasmid-encoded phosphoethanolamine transferase gene mcr-1

Novel Polymyxin Combination with the Antiretroviral Zidovudine Exerts Synergistic Killing against NDM-Producing Multidrug-Resistant Klebsiella pneumoniae

In vitro pharmacokinetics/pharmacodynamics of continuous ceftazidime infusion alone and in combination with colistin against Pseudomonas aeruginosa biofilm

Phage resistance in Klebsiella pneumoniae and bidirectional effects impacting antibiotic susceptibility

Suchergebnisse filtern